Regulatory aspects of vaccines

Research output: Contribution to journalArticlepeer-review

Abstract

in order to get a marketing authorisation, a vaccine product must fullfill the national/international requriements for efficiency, safety and quality. Due to its complex structure, the manufacture, control and regulation of a vaccine requires special expertise and procedures when compared to that of a small molecule drug. in this paper, the registration procedures of vaccines in different countries including Turkey, european Union, UsA and the countries covered by the world Health Organization (wHO) will be reviewed and the regulatory requirements and related guidelines are summarised.

Translated title of the contributionAşılarda yasal düzenlemeler
Original languageEnglish
Pages (from-to)153-160
Number of pages8
JournalFabad Journal of Pharmaceutical Sciences
Volume45
Issue number2
Publication statusPublished - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • European Medicines Agency (eMA)
  • Food and Drug Administration (FDA)
  • Marketing authorisation
  • Regulatory
  • Turkish Medicines and Medical Devices Agency (tMMDA)
  • Vaccines
  • World Health Organization

Fingerprint

Dive into the research topics of 'Regulatory aspects of vaccines'. Together they form a unique fingerprint.

Cite this